Results 61 to 70 of about 48,450 (199)

Rituximab for the treatment of fatigue in primary biliary cholangitis (formerly primary biliary cirrhosis): a randomised controlled trial

Efficacy and Mechanism Evaluation, 2018
Background: Primary biliary cirrhosis (PBC) is an autoimmune liver disease, and 50% of patients with this disease experience fatigue. This is a debilitating symptom affecting quality of life and resulting in social isolation, which is highlighted by ...
Amardeep Khanna, Laura Jopson, Denise Howel, Andrew Bryant, Andrew Blamire, Julia L Newton, Jennifer Wilkinson, Alison J Steel, Jennifer Bainbridge, Renae Stefanetti, Sophie Cassidy, David Houghton, David E Jones   +12 more
doaj   +1 more source

Hepatic manifestations of celiac disease

Clinical and Experimental Gastroenterology, 2010
Hugh James FreemanDepartment of Medicine (Gastroenterology), University of British Columbia, Vancouver, British Columbia, CanadaAbstract: Different hepatic and biliary tract disorders may occur with celiac disease.
Hugh James Freeman
doaj  

Sex Differences Associated with Primary Biliary Cirrhosis

Clinical and Developmental Immunology, 2012
Primary biliary cirrhosis (PBC) is a cholestatic liver disease of autoimmune origin, characterised by the destruction of small intrahepatic bile ducts. The disease has an unpredictable clinical course but may progress to fibrosis and cirrhosis.
Daniel S. Smyk, Eirini I. Rigopoulou, Albert Pares, Charalambos Billinis, Andrew K. Burroughs, Luigi Muratori, Pietro Invernizzi, Dimitrios P. Bogdanos   +7 more
doaj   +1 more source

Primary biliary cirrhosis and psoriasis: a two-sample Mendelian randomization study. [PDF]

Front Immunol, 2023
Zhao D, Zhao Q, Xu F, Zhang F, Bai W.
europepmc   +1 more source

Primary biliary cirrhosis and osteoporosis: a bidirectional two-sample Mendelian randomization study. [PDF]

Front Immunol, 2023
Zhao D, Li G, Bai W, Teng J, Yan B, Han C.   +5 more
europepmc   +1 more source

Autoimmune liver diseases: internist’s guide from bench to bedside

Italian Journal of Medicine, 2015
Autoimmune liver diseases are disorders of unknown etiology and immune pathogenesis, characterized by liver parenchyma inflammation (autoimmune hepatitis) or by lesions of the intralobular biliary ducts (primary biliary cirrhosis) or of the entire ...
Mario Visconti
doaj   +1 more source

Beyond a Conduit: The Evolution of Functional Biliary Stents From Active Intervention to Enabling Platforms

iNew Medicine, EarlyView.
This review traces the evolution of functional biliary stents, outlining the paradigm shift from “active intervention” strategies that target stent failure to next‐generation “enabling platforms.” These platforms leverage biodegradable materials, 3D/4D printing, and smart sensors to achieve personalized, regenerative, and theranostic solutions ...
Muhan Li, Xu Liu, Xin Ye, Zhixia Dong, Xinjian Wan   +4 more
wiley   +1 more source

Antimitochondrial antibody-negative primary biliary cirrhosis with secondary Sjogren syndrome: a case report. [PDF]

Ann Med Surg (Lond), 2023
Acharya S, Shrestha S, Poddar E, Neupane A, Khadayat R, Magar SR, Lamsal M, Pathak R.   +7 more
europepmc   +1 more source

Novel Approach to Bile Duct Damage in Primary Biliary Cirrhosis: Participation of Cellular Senescence and Autophagy

International Journal of Hepatology, 2012
Primary biliary cirrhosis (PBC) is characterized by antimitochondrial autoantibodies (AMAs) in patients' sera and histologically by chronic nonsuppurative destructive cholangitis in small bile ducts, eventually followed by extensive bile duct loss and ...
Motoko Sasaki, Yasuni Nakanuma
doaj   +1 more source

Comparative Outcomes of Endoscopic Treatment for Symptomatic and Asymptomatic Common Bile Duct Stones in the Elderly: A Propensity Score‐Based Cohort Analysis

Journal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
ABSTRACT Introduction Various guidelines recommend endoscopic stone removal for asymptomatic common bile duct stones (CBDS); however, previous studies have indicated that asymptomatic CBDS is associated with a higher incidence of post‐ERCP pancreatitis (PEP).
Kota Shimojo, Akinori Maruta, Keisuke Iwata, Yuhei Iwasa, Mitsuru Okuno, Kensaku Yoshida, Shinya Uemura, Tsuyoshi Mukai, Takuji Iwashita, Masahito Shimizu   +9 more
wiley   +1 more source